Jasper Therapeutics annual net debt
2020
2021
2022
2023
2024
2025
Jasper Therapeutics Net Debt Growth & History (JSPR)
Jasper Therapeutics's net debt was −$27.5M for fiscal 2025.
View full Jasper Therapeutics company overviewJasper Therapeutics annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$27.5M | $42.4M | — |
| 2024 | 2024-12-31 | −$69.8M | $14.3M | — |
| 2023 | 2023-12-31 | −$84.1M | −$46.9M | — |
| 2022 | 2022-12-31 | −$37.2M | $46.8M | — |
| 2021 | 2021-12-31 | −$83.9M | −$64.6M | — |
| 2020 | 2020-12-31 | −$19.4M | — | — |
Jasper Therapeutics quarterly net debt
Q4.20
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$7.0M | $30.3M | — |
| Q1 2026 | 2026-03-31 | −$13.4M | $32.8M | — |
| Q4 2025 | 2025-12-31 | −$27.5M | $42.4M | — |
| Q3 2025 | 2025-09-30 | −$49.2M | $41.2M | — |
| Q2 2025 | 2025-06-30 | −$37.4M | $67.1M | — |
| Q1 2025 | 2025-03-31 | −$46.2M | $69.7M | — |
| Q4 2024 | 2024-12-31 | −$69.8M | $14.3M | — |
| Q3 2024 | 2024-09-30 | −$90.4M | $10.4M | — |
| Q2 2024 | 2024-06-30 | −$104.5M | $8.1M | — |
| Q1 2024 | 2024-03-31 | −$115.9M | $10.0M | — |
| Q4 2023 | 2023-12-31 | −$84.1M | −$46.9M | — |
| Q3 2023 | 2023-09-30 | −$100.9M | −$53.8M | — |
| Q2 2023 | 2023-06-30 | −$112.6M | −$55.8M | — |
| Q1 2023 | 2023-03-31 | −$126.0M | −$59.5M | — |
| Q4 2022 | 2022-12-31 | −$37.2M | $46.8M | — |
| Q3 2022 | 2022-09-30 | −$47.1M | $50.8M | — |
| Q2 2022 | 2022-06-30 | −$56.8M | — | — |
| Q1 2022 | 2022-03-31 | −$66.5M | — | — |
| Q4 2021 | 2021-12-31 | −$83.9M | −$64.6M | — |
| Q3 2021 | 2021-09-30 | −$97.9M | — | — |
| Q4 2020 | 2020-12-31 | −$19.4M | — | — |
Jasper Therapeutics net debt trends
Over the last five fiscal years, Jasper Therapeutics's net debt decreased from −$19.4M to −$27.5M, a change of −$8.1M. The latest reported quarter, Q2 2026, shows −$7.0M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Jasper Therapeutics source filings ↗